The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, 14th July 2025.
Prof. Opuni, who previously served as the Board Chairman of the FDA, steps into the role following the departure of Dr. Delese Darko.
Dr. Darko, who led the Authority as CEO since 2017, was recently appointed as the Director General of the Africa Medicines Agency (AMA), a position that underscores her contributions to public health both in Ghana and across the continent.
In a statement issued on Monday, the FDA expressed its appreciation to Dr. Darko for her dedicated service over the past eight years and conveyed its confidence in Prof. Opuni’s ability to lead the Authority into a new chapter.
“The FDA extends its warmest congratulations to Prof. Opuni on his appointment and looks forward to his leadership in advancing the Authority’s mandate of safeguarding public health and safety,” the statement read.
Prof. Opuni brings to the position a wealth of experience in public health, regulatory affairs, and academia, which is expected to strengthen the FDA’s capacity to ensure the safety and quality of food, drugs, cosmetics, and other regulated products in Ghana.
His leadership comes at a critical time as the FDA continues to tackle challenges such as counterfeit medicines, food safety issues, and the need for increased public education on regulatory compliance.




